Cognoa to Present and Exhibit at the 2021 American Academy of Pediatrics (AAP) National Conference and Exhibition

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

PALO ALTO, Calif., Oct. 8, 2021 /PRNewswire/ -- Cognoa , a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced it will be presenting and exhibiting at the 2021 American Academy of Pediatrics (AAP) Annual National Conference and Exhibition , which will be held virtually October 8 11, 2021.

Metadata
Provider: 
PR NewswirePR Newswire
Retrieved on: 
Friday, October 8, 2021
Information
Tags: 
FAAP, Autism, CDT, Conference, Physician, Use, Diagnosis, PALO, FDA, American Academy of Pediatrics, AAP, Exhibition, American Academy, Intelligence, Chief Medical Officers (United Kingdom), Medical device
Geotags: 
Israel, California, ALTO
Organisation: 
COGNOA
Website: 
https://www.cognoa.com/
Summary
Key Points: 
  • PALO ALTO, Calif., Oct. 8, 2021 /PRNewswire/ -- Cognoa , a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced it will be presenting and exhibiting at the 2021 American Academy of Pediatrics (AAP) Annual National Conference and Exhibition , which will be held virtually October 8 11, 2021.
  • Cognoa will showcase Canvas Dx , an AI-based diagnosis aid designed to help physicians diagnose autism in the primary care setting and the first diagnosis aid for autism authorized for commercialization by the FDA.
  • Cognoa will begin making Canvas Dx available by prescription in the U.S. in the coming weeks.
  • Available to registered attendees, sessions relevant to the diagnosis of autism and the current and potential future use of artificial intelligence in pediatric practice at the 2021 AAP National Conference and Exhibition include:


Cognoa to Present and Exhibit at the 2021 American Academy of Pediatrics (AAP) National Conference and Exhibition

PALO ALTO, Calif., Oct. 8, 2021 /PRNewswire/ -- Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced it will be presenting and exhibiting at the 2021 American Academy of Pediatrics (AAP) Annual National Conference and Exhibition, which will be held virtually October 8 – 11, 2021.

Cognoa will showcase Canvas Dx™, an AI-based diagnosis aid designed to help physicians diagnose autism in the primary care setting and the first diagnosis aid for autism authorized for commercialization by the FDA. Cognoa will begin making Canvas Dx available by prescription in the U.S. in the coming weeks.

Sharief Taraman, MD, FAAP, Chief Medical Office at Cognoa, will be presenting the pivotal study data on Canvas Dx in the virtual poster hall, available from October 8 through January 2022, in a poster titled "Performance of a Novel Software-Based Autism Spectrum Disorder Diagnosis Aid for Use in a Primary Care Setting." 

Cognoa representatives will also be available at the Canvas Dx virtual booth on Saturday, October 9 from 12:15 p.m. – 4:00 p.m. CDT; Sunday, October 10 from 10:00 a.m. – 4:00 p.m. CDT; and Monday, October 11 from 10:00 a.m. – 2:00 p.m. CDT. 

Available to registered attendees, sessions relevant to the diagnosis of autism and the current and potential future use of artificial intelligence in pediatric practice at the 2021 AAP National Conference and Exhibition include:

VH1200 Section on Administration and Practice Management Program
Date and Time: October 9, 8:00 a.m. – 12:00 p.m. CT

VH1221 Joint Program: Council on Children With Disabilities and Section on Developmental and Behavioral Pediatrics
Understanding Mental Health Disorders in Children With Neurodevelopmental Disabilities
Date and Time: October 9, 9:00 a.m. - 11:00 a.m. CT

VH1303 Joint Program: Section on Emergency Medicine, Section on Developmental and Behavioral Pediatrics, and Council on Children With Disabilities
Establishing Trust and Engaging Children in the Emergency Department
Date and Time: October 10, 8:00 a.m. - 12:00 p.m. CT

On-Demand Sessions:
OD0001: 25 Tips to Improve Your Practice
OD0042: Beyond Diagnosis: Autism Management for the General Pediatrician: Part 1
OD0043: Beyond Diagnosis: Autism Management for the General Pediatrician: Part 2
OD0080: Demystifying the Evaluation of Children With Intellectual Disability

About Cognoa
Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions with the goals of enabling equitable access to care and improving the lives and outcomes of children and families living with behavioral conditions, starting with autism. Cognoa's products are intended to be routinely prescribed by providers and covered by insurers. For more information, visit https://www.cognoa.com/. 

Media Contact
Joseph Moses
Headline Media
E: [email protected]
T: +44 7308349833

 

Cision View original content:https://www.prnewswire.com/news-releases/cognoa-to-present-and-exhibit-at-the-2021-american-academy-of-pediatrics-aap-national-conference-and-exhibition-301395449.html

SOURCE Cognoa

Copyright: 
2021 PR Newswire. All Rights Reserved.